IPX LLC is a research and development company responsible for
the R&D and evaluation of low-temperature plasma technology.
Building a clean industrial foundation for the future with low-temperature plasma.
IPX LLC is a research and development company specializing in the fundamental research, applied development, and performance evaluation of low-temperature plasma.
Working together with PX Co., Ltd., which handles the product business, we bridge research-stage technology to practical use.
Building on the low-temperature plasma expertise, patents, and validation data we have accumulated, we advance research and development to solve challenges in the environmental, medical, and energy sectors.
We conduct research and development of low-temperature plasma technology, as well as the design and evaluation of applied products.
Fundamental research and applied development of low-temperature plasma. We work on the design and improvement of electrodes, reactors, and processes.
Performance evaluation of gas decomposition, water treatment, sterilization, and deodorization, along with verification carried out in cooperation with third-party institutions.
Through co-creation with universities, companies, and government bodies, we advance the social implementation of research results.
Research and development of technology for decomposing CO₂ and greenhouse gases using low-temperature plasma.
Technology and evaluation for the sterilization of air, water, and surfaces, and the inactivation of viruses.
Technology for decomposing and neutralizing odor components and harmful substances such as VOCs.
Applied research for the medical and beauty sectors, including cell activation using plasma.
The PX Series inherits the low-temperature plasma technology we have researched and developed. It is a next-generation model of the air sterilization and deodorization device "SterilizAir," reimagined in performance, functionality, and design on the occasion of the company name change.
Built on the technology and track record cultivated to date, it pursues higher sterilization and deodorization performance, superior safety, and ease of use. Reborn as a next-generation low-temperature plasma air environment solution equipped with the latest low-temperature plasma technology, it will be released by PX Co., Ltd.
We have accumulated extensive research, development, and validation of low-temperature plasma.
Our low-temperature plasma technology was registered and showcased on the official website of the Conference of the Parties (COP) to the UN Framework Convention on Climate Change.
We are conducting demonstration trials in the CO₂ and flue-gas fields at major cement plants and thermal power stations.
Adoption and evaluation are progressing across a wide range of settings, including medical institutions (such as ICUs and HCUs) as well as the food and defense sectors.
We have filed patents in Japan and internationally covering environmental sterilization, CO₂ treatment, plasma generation, and more, forming our intellectual property foundation.
| Company Name | IPX LLC |
| Established | October 2003 |
| Business | Research & development, performance evaluation, and joint research of low-temperature plasma technology |
| Representative Partner | Hidetaka Miyazaki |
| Location | Sankyu Building 3F, 3-6-14 Kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan |
Inquiries regarding research and development, joint research, and performance evaluation are handled through the contact form of PX Co., Ltd.
Go to contact form